tiprankstipranks
Advertisement
Advertisement

HK:6990 Stock Latest News

Kelun-Biotech Drops Biotech Marker After Meeting Main Board Listing Thresholds
Company AnnouncementsKelun-Biotech Drops Biotech Marker After Meeting Main Board Listing Thresholds
11h ago
6990
Sichuan Kelun-Biotech Wins Approval for Full Circulation of Additional H Shares
PremiumCompany Announcements
Sichuan Kelun-Biotech Wins Approval for Full Circulation of Additional H Shares
1d ago
6990
Kelun-Biotech Wins CSRC Nod for H Share Full Circulation
PremiumCompany Announcements
Kelun-Biotech Wins CSRC Nod for H Share Full Circulation
13d ago
6990
Kelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
PremiumRatings
Kelun-Biotech: Transitioning to Commercial Growth with sac-TMT as a Key Value Driver Supporting a Sustained Buy Rating
15d ago
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
PremiumCompany Announcements
Kelun-Biotech Wins NMPA Green Light to Begin Trials of Novel Bispecific ADC SKB103
17d ago
6990
Kelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
PremiumCompany AnnouncementsKelun-Biotech Widens Losses as It Accelerates ADC Push and Wins New China Approvals
17d ago
6990
Kelun-Biotech’s Sacituzumab Tirumotecan Strengthens Lead in EGFR-Mutant Lung Cancer With Final Survival Data
Premium
Company Announcements
Kelun-Biotech’s Sacituzumab Tirumotecan Strengthens Lead in EGFR-Mutant Lung Cancer With Final Survival Data
22d ago
6990
Kelun-Biotech Sets March 2026 Board Meeting and Webcast for 2025 Results
Premium
Company Announcements
Kelun-Biotech Sets March 2026 Board Meeting and Webcast for 2025 Results
29d ago
6990
Kelun-Biotech Signs Connected Marketing Deal for Key TROP2 Cancer Drug
PremiumCompany Announcements
Kelun-Biotech Signs Connected Marketing Deal for Key TROP2 Cancer Drug
1M ago
6990
Kelun-Biotech Wins NMPA IND Nod for Long-Acting Atopic Dermatitis Antibody
PremiumCompany Announcements
Kelun-Biotech Wins NMPA IND Nod for Long-Acting Atopic Dermatitis Antibody
1M ago
6990
Kelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
PremiumCompany Announcements
Kelun-Biotech Wins Fourth China Indication for Core TROP2 ADC in Advanced Breast Cancer
2M ago
6990
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
PremiumCompany Announcements
Kelun-Biotech Details Pricing Controls for 2026 Connected R&D Procurement
3M ago
6990
Kelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
PremiumCompany AnnouncementsKelun-Biotech Signs New Connected R&D Goods Supply Deal With China Resources Kelun
3M ago
6990
Sichuan Kelun-Biotech Cancels RMB980 Million Structured Deposit Subscription
Premium
Company Announcements
Sichuan Kelun-Biotech Cancels RMB980 Million Structured Deposit Subscription
3M ago
6990
Kelun-Biotech Commits RMB1.82 Billion to New Structured Deposits With BOC and BOCOM
Premium
Company Announcements
Kelun-Biotech Commits RMB1.82 Billion to New Structured Deposits With BOC and BOCOM
3M ago
6990
Kelun-Biotech’s ADC-PD-1 Combo Wins Breakthrough Therapy Status in First-Line Lung Cancer
PremiumCompany Announcements
Kelun-Biotech’s ADC-PD-1 Combo Wins Breakthrough Therapy Status in First-Line Lung Cancer
3M ago
6990
Kelun-Biotech Wins NMPA IND Nod for ITGB6-Targeted ADC SKB105 and Advances Oncology Collaboration With Crescent
PremiumCompany Announcements
Kelun-Biotech Wins NMPA IND Nod for ITGB6-Targeted ADC SKB105 and Advances Oncology Collaboration With Crescent
3M ago
6990
Kelun-Biotech Renews Connected Distribution Deal With China Resources Kelun to 2028
PremiumCompany Announcements
Kelun-Biotech Renews Connected Distribution Deal With China Resources Kelun to 2028
3M ago
6990
Kelun-Biotech Wins Strong Shareholder Backing for 2026 Connected Deals and New Share Incentive Plan
PremiumCompany Announcements
Kelun-Biotech Wins Strong Shareholder Backing for 2026 Connected Deals and New Share Incentive Plan
3M ago
6990
Sichuan Kelun-Biotech Settles Disputes with MediLink Therapeutics
PremiumCompany AnnouncementsSichuan Kelun-Biotech Settles Disputes with MediLink Therapeutics
4M ago
6990
Sichuan Kelun-Biotech Announces Key Agreements for 2026
Premium
Company Announcements
Sichuan Kelun-Biotech Announces Key Agreements for 2026
4M ago
6990
Sichuan Kelun-Biotech’s Products Gain National Reimbursement Approval and New Agreements
Premium
Company Announcements
Sichuan Kelun-Biotech’s Products Gain National Reimbursement Approval and New Agreements
4M ago
6990

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >